4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-022219
President and CEO sold 5,407 shares at an average $0.68 ($3,702)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lucchino David L. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-04 | Sale : show line 1 in the form 10b5-1 | −2,550 | $0.69 | $1,760 | 664,792 | D |
| 2023-08-07 | Sale : show line 2 in the form 10b5-1 | −2,857 | $0.68 | $1,943 | 661,935 | D |
| Open-market sales · 5,407 sh · avg $0.68 · $3,702 | ||||||
Loading xslF345X05/form4.xml…